ProMIS Neurosciences (PMN) Earnings Date, Estimates & Call Transcripts $1.23 +0.00 (+0.07%) (As of 10:10 AM ET) Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Earnings SummaryUpcoming Earnings DateNov. 12EstimatedActual EPS (Aug. 8) -$0.13 Beat By $0.01 Consensus EPS (Aug. 8) -$0.14 Conference Call TranscriptConference Call Audio Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenuePMN Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.PMN Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad Stansberry ResearchShocking prediction from firm that predicted President KamalaPrepare for President Kamala I won't be voting for her. Even so, I'm worried VP Kamala Harris could pull off a victory and become our next president. And it would be much worse than anything you might expect—especially when it comes to your money. Because likely WON'T get a second chance at recovering the money you stand to lose if she takes power.Find out how to prepare. ProMIS Neurosciences Analyst EPS EstimatesCurrent Year EPS Consensus Estimate:($0.24) EPSNext Year EPS Consensus Estimate: ($0.21) EPSPMN Earnings Date and InformationProMIS Neurosciences last released its earnings data on August 8th, 2024. The reported ($0.13) EPS for the quarter, topping analysts' consensus estimates of ($0.14) by $0.01. ProMIS Neurosciences has generated ($0.74) earnings per share over the last year (($0.74) diluted earnings per share). Earnings for ProMIS Neurosciences are expected to grow in the coming year, from ($0.24) to ($0.21) per share. ProMIS Neurosciences has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, November 12th, 2024 based off prior year's report dates.Read More ProMIS Neurosciences Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueLinks 11/12/2024(Estimated)------- 8/8/2024-($0.14)($0.13)+$0.01($0.13)-- 5/14/2024Q1 2024-($0.19)($0.19)($0.19)--4/1/2024Q4 2023-($0.09)($0.09)($0.09)--11/14/2023Q3 2023-($0.19)($0.19)($0.19)--8/14/2023Q2 2023-($0.27)($0.27)($0.27)--5/15/2023Q1 2023-($0.58)($0.58)($0.58)--Shocking prediction from firm that predicted President Kamala (Ad)Prepare for President Kamala I won't be voting for her. Even so, I'm worried VP Kamala Harris could pull off a victory and become our next president. And it would be much worse than anything you might expect—especially when it comes to your money. Because likely WON'T get a second chance at recovering the money you stand to lose if she takes power.Find out how to prepare.3/8/2023Q4 2022-($0.90)($0.90)($0.90)--11/14/2022Q3 2022-($0.85)($0.85)($0.85)--8/12/2022Q2 2022-($0.38)($0.38)($0.38)--5/13/2022Q1 2022-($0.60)($0.60)($0.60)-$0.01 million5/13/2020Q1 2020-($0.60)($0.60)($0.60)--3/18/2020Q4 2019-($0.60)($0.60)($0.60)--11/14/2019Q3 2019-($0.60)($0.60)($0.60)-- ProMIS Neurosciences Earnings - Frequently Asked Questions When is ProMIS Neurosciences's earnings date? ProMIS Neurosciences has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, November 12th, 2024 based off last year's report dates. Learn more on PMN's earnings history. Did ProMIS Neurosciences beat their earnings estimates last quarter? In the previous quarter, ProMIS Neurosciences (NASDAQ:PMN) reported ($0.13) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.14) by $0.01. Learn more on analysts' earnings estimate vs. PMN's actual earnings. How can I listen to ProMIS Neurosciences's earnings conference call? The conference call for ProMIS Neurosciences's latest earnings report can be listened to online. Listen to Conference Call How can I read ProMIS Neurosciences's conference call transcript? The conference call transcript for ProMIS Neurosciences's latest earnings report can be read online. Read Transcript How much revenue does ProMIS Neurosciences generate each year? ProMIS Neurosciences (NASDAQ:PMN) has a recorded annual revenue of $10,000.00. How much profit does ProMIS Neurosciences generate each year? ProMIS Neurosciences (NASDAQ:PMN) has a recorded net income of -$13.21 million. PMN has generated -$0.74 earnings per share over the last four quarters. What is ProMIS Neurosciences's EPS forecast for next year? ProMIS Neurosciences's earnings are expected to grow from ($0.24) per share to ($0.21) per share in the next year. More Earnings Resources from MarketBeat Related Companies: SNOA Earnings ANVS Earnings CLSD Earnings OPTN Earnings HOWL Earnings CTMX Earnings KPTI Earnings CASI Earnings TRVN Earnings CTXR Earnings Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: GameStop: Earnings Won’t Save It, Dilution Points to TroubleIs Merck Stock Undervalued After Its Colossal Earnings Growth?Polestar Lives to Fight Another Day After Q2 EarningsWhy NVIDIA’s Earnings Point to a Bullish Future for Pure StorageDoes A&F's Q2 Earnings Win Point to a Strong Holiday Season?Salesforce Beats Earnings, Raises Full-Year Profit OutlookDon’t Count Out CrowdStrike Yet: Key Insights from Q2 Earnings This page (NASDAQ:PMN) was last updated on 9/20/2024 by MarketBeat.com Staff From Our PartnersNew President Kamala warningFinancial nightmare coming after election In 2018, one independent research predicted Kamala Harris was on ...Stansberry Research | SponsoredAct by Friday, August 16th, to collect this 22% dividendLet's do a little math here... To double your money at a 3% rate of return, you would need around 23 years....Investors Alley | SponsoredThis Crypto Is Set to Explode in SeptemberWith thousands of cryptocurrencies out there, it's crucial to focus on the ONE that has the potential to make ...Crypto 101 Media | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnlock the Secret to Easy Wins with Iron CondorsDiscover the power of Iron Condor trades – a low-risk, high-reward strategy that allows you to profit consiste...Netpicks | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredMan who Predicted Trump 2016 Win: “Prepare for Election Meltdown”Former advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | SponsoredForget ChatGPT: Follow the AI Retirement PlaybookEveryone’s talking about AI right now, but I’ve been talking about it for years. Follow this two-part playb...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist My Default Watchlist Adding ProMIS Neurosciences, Inc. You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Please log in to your account or sign up in order to add this asset to your watchlist. Share ProMIS Neurosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Questions? Get Started with MarketBeat — Read Your Daily NewsletterCheck Out My MarketBeatWatch Our Tutorial VideosAdd a Stock to Your WatchlistSet Up an Instant AlertView a Company's Profile PageView Our Financial CalendarsView Today's Analyst Ratings Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.